The Technical Analyst
Select Language :
Praxis Precision [PRAX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Praxis Precision Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Praxis Precision is listed at the  Exchange

3.07% $61.02

America/New_York / 28 mar 2024 @ 16:00


Praxis Precision: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 807.80 mill
EPS: -18.69
P/E: -3.26
Earnings Date: May 08, 2024
SharesOutstanding: 13.24 mill
Avg Daily Volume: 0.183 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -3.26 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.55x
Company: PE -3.26 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.0133
(-99.98%) $-61.01
Date: 2024-03-28
Expected Trading Range (DAY)

$ 57.05 - 64.77

( +/- 6.33%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-12 Mastrocola Lauren Sell 48 Common Stock
2024-02-12 Nemiroff Alex Sell 51 Common Stock
2024-02-12 Souza Marcio Sell 271 Common Stock
2024-01-12 Kelly Timothy Edwin Buy 30 000 Stock Option (Right to Buy)
2024-01-12 Souza Marcio Buy 100 000 Stock Option (Right to Buy)
INSIDER POWER
98.15
Last 99 transactions
Buy: 3 195 196 | Sell: 875 304

Forecast: 16:00 - $61.02

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $61.02
Forecast 2: 16:00 - $61.02
Forecast 3: 16:00 - $61.02
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $61.02 (3.07% )
Volume 1.769 mill
Avg. Vol. 0.183 mill
% of Avg. Vol 964.00 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Praxis Precision Medicines, Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Praxis Precision Medicines, Inc

RSI

Intraday RSI14 chart for Praxis Precision Medicines, Inc

Last 10 Buy & Sell Signals For PRAX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$45.25N/AActive
Profile picture for
            Praxis Precision Medicines, Inc

PRAX

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide (ASO) for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement with Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Last 10 Buy Signals

Date Signal @
RLCUSDMar 28 - 17:02$4.01
PSGUSDMar 28 - 17:015.30
TOMOUSDMar 28 - 14:10$1.091
FARMUSDMar 28 - 17:0153.54
MEDIAUSDMar 28 - 16:5823.37
ICXUSDMar 28 - 16:56$0.361
ROSEUSDMar 28 - 16:55$0.141
APTUSDMar 28 - 16:5017.00
BIFIUSDMar 28 - 16:48445.95
WSTETHUSDMar 28 - 16:494 124.37

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.